175 related articles for article (PubMed ID: 30410358)
41. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases.
Ni PZ; Yang YS; Hu WP; Wang WP; Yuan Y; Chen LQ
J Thorac Dis; 2016 Oct; 8(10):2689-2696. PubMed ID: 27867543
[TBL] [Abstract][Full Text] [Related]
42. Adenosquamous Carcinoma with the Acantholytic Feature in the Oral Cavity: A Case Report and Comprehensive Literature Review.
Abé T; Yamazaki M; Maruyama S; Ikeda N; Sumita Y; Tomihara K; Tanuma JI
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292088
[TBL] [Abstract][Full Text] [Related]
43. Adenosquamous Carcinoma of the Stomach: A Population-based Study from the SEER Database.
Ge Y; Lin L; Ma X; Luo D; Shi L; Jiang M; Fan H; He Y; Yang L; Xu Z
J Cancer; 2019; 10(23):5705-5713. PubMed ID: 31737107
[No Abstract] [Full Text] [Related]
44. [A clinicopathological study of adenosquamous carcinoma of the lung].
Mukaida T; Aoe M; Yamashita M; Date H; Hara K; Andoh A; Shimizu Y
Kyobu Geka; 1996 Nov; 49(12):975-9; discussion 979-81. PubMed ID: 8936996
[TBL] [Abstract][Full Text] [Related]
45. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
46. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
Cao L; Wen H; Feng Z; Han X; Wu X
Int J Gynecol Cancer; 2019 Oct; 29(8):1244-1251. PubMed ID: 31422351
[TBL] [Abstract][Full Text] [Related]
47. A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan.
Lan YT; Huang KH; Liu CA; Tai LC; Chen MH; Chao Y; Li AF; Chiou SH; Shyr YM; Wu CW; Fang WL
PLoS One; 2015; 10(10):e0139748. PubMed ID: 26445240
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
49. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
[TBL] [Abstract][Full Text] [Related]
50. Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.
Jin Z; Holubek M; Sukov WR; Sattler CA; Wiktor AE; Jenkins RB; Wu TT; Yoon HH
Am J Clin Oncol; 2019 Feb; 42(2):190-195. PubMed ID: 30516569
[TBL] [Abstract][Full Text] [Related]
51. Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.
Lee Y; Chung JH; Kim SE; Kim TJ; Lee KW
Clin Nucl Med; 2014 Feb; 39(2):107-12. PubMed ID: 23751831
[TBL] [Abstract][Full Text] [Related]
52. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases.
Yachida S; Nakanishi Y; Shimoda T; Nimura S; Igaki H; Tachimori Y; Kato H
Oncology; 2004; 66(3):218-25. PubMed ID: 15218313
[TBL] [Abstract][Full Text] [Related]
53. HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.
Mizuno T; Kojima Y; Yonemori K; Yoshida H; Sugiura Y; Ohtake Y; Okuma HS; Nishikawa T; Tanioka M; Sudo K; Shimomura A; Noguchi E; Kato T; Shimoi T; Uno M; Ishikawa M; Fujiwara Y; Ohe Y; Tamura K
Oncol Lett; 2020 Oct; 20(4):38. PubMed ID: 32802162
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
55. Primary Hepatic Adenosquamous Carcinoma Associated with Primary Sclerosing Cholangitis.
Yamao K; Takenaka M; Imai H; Nakai A; Omoto S; Kamata K; Minaga K; Miyata T; Sakurai T; Watanabe T; Nishida N; Matsumoto I; Takeyama Y; Chikugo T; Kudo M
Oncology; 2017; 93 Suppl 1():76-80. PubMed ID: 29258074
[TBL] [Abstract][Full Text] [Related]
56. Oral adenosquamous carcinoma: Report of a rare entity with a special insight on its histochemistry.
Sravya T; Rao GV; Kumar MP; Sudheerkanth K
J Oral Maxillofac Pathol; 2016; 20(3):548. PubMed ID: 27721632
[TBL] [Abstract][Full Text] [Related]
57. High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma.
Zhu Q; Luo R; Gu J; Hou Y; Chen Z; Xu F; Wang L; Mao W; Lu C; Ge D
J Cancer; 2020; 11(4):810-818. PubMed ID: 31949484
[No Abstract] [Full Text] [Related]
58. Adenosquamous Carcinoma of the Esophagus: A Literature Review.
Schizas D; Kapsampelis P; Mylonas KS
J Transl Int Med; 2018 Jun; 6(2):70-73. PubMed ID: 29984200
[TBL] [Abstract][Full Text] [Related]
59. EphA10 and EphB3 are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Yan HX; Li QL; Cai WW; Tang D; Wang B; Liu X; Liu ZD; Yang ZL
Int J Clin Exp Pathol; 2018; 11(2):512-525. PubMed ID: 31938137
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
